PreciseDx, a pioneering medical technology leveraging the power of artificial intelligence (AI) to improve diagnostics in oncology, has secured $20.7 million in a series B funding round to accelerate growth and expansion. Co-founded in 2020 by Jack Zeineh MD, and Gerardo Fernandez MD, the companyโs latest financing round was spearheaded by Eventide Asset Management, supported
read more..